作者: M. Joubert , Y. Reznik
DOI: 10.1016/J.DIABRES.2011.12.010
关键词:
摘要: Aim: Despite recent advances in diabetes therapy including the new long- and rapid-insulin analogs, insulin intensification strategies such as basal/bolus or pump sophis- ticated methods for titration derived from principles of functional therapy, many patients fail to reach maintain target glycosylated hemoglobin (HbA1c) values, putting them at increased risk vascular complications. Continuous glucose monitoring (CGM) systems represent an important advance technology that can facilitate optimal control type 1 diabetes. Method: This review focuses on efficacy safety CGM man- agement. The different devices available are also described, way use educational approach patient a step-by-step progression toward glycemic control. Results: In diabetes, associated with 0.5-1% reduction HbA1c without hypoglycemia. correlates compliance sensor wear, whatever patient's age range. Conclusion: Efficacy is now proven but indications, terms issues this still need be specified.